Press Releases
All Releases
View Summary Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards
May 1, 2014
PDF 8.6 KB Add to Briefcase
View Summary Enzon Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends
Apr 23, 2013
PDF 9.5 KB Add to Briefcase
View Summary Enzon Reports Fourth Quarter and Full Year 2012 Results
Mar 18, 2013
PDF 18.6 KB Add to Briefcase
View Summary Enzon to Review Asset Sales, Sale of the Company
Dec 17, 2012
PDF 8.3 KB Add to Briefcase
View Summary Enzon Announces Special Dividend
Nov 29, 2012
PDF 7.7 KB Add to Briefcase
View Summary Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China
Nov 8, 2012
PDF 10.4 KB Add to Briefcase
View Summary Enzon Reports Third Quarter 2012 Results
Oct 31, 2012
PDF 15.8 KB Add to Briefcase
View Summary Enzon to Present at 2012 World Congress and Expo on Biowaivers and Biosimilars
Sep 11, 2012
PDF 9.7 KB Add to Briefcase
View Summary Enzon Reports Second Quarter 2012 Results
Aug 1, 2012
PDF 16.3 KB Add to Briefcase
View Summary Enzon Presents Pre-Clinical Data on Controlled Release of PEGylated Interferon-Beta-1b and PEGylated anti-TNF-a Antibody Fragment at the Controlled Release Society Annual Meeting
Jul 16, 2012
PDF 48.1 KB Add to Briefcase
View Summary Enzon Announces Data From Phase I Study of PEG-SN38 in Pediatric Neuroblastoma and Other Solid Tumors Presented at 2012 Advances in Neuroblastoma Research Conference
Jun 19, 2012
PDF 9.6 KB Add to Briefcase
View Summary Enzon Presents Final Analysis of Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer at 2012 ASCO Meeting
Jun 4, 2012
PDF 10.4 KB Add to Briefcase
View Summary Enzon and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China
May 7, 2012
PDF 11.3 KB Add to Briefcase
View Summary Enzon Reports First Quarter 2012 Results
May 2, 2012
PDF 14.3 KB Add to Briefcase
View Summary Enzon Reports Fourth-Quarter and Full-Year 2011 Results
Mar 12, 2012
PDF 56.8 KB Add to Briefcase
View Summary Enzon Presents Data From Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer
Dec 8, 2011
PDF 10.2 KB Add to Briefcase
View Summary Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
Nov 12, 2011
PDF 12.6 KB Add to Briefcase
View Summary Enzon Reports 3rd Quarter 2011 Results
Nov 3, 2011
PDF 51.6 KB Add to Briefcase
View Summary Enzon Announces Management Change, Forms Special Committee of the Board
Oct 17, 2011
PDF 8.8 KB Add to Briefcase
View Summary Enzon Announces Reduction in Force to Align Operations with Research and Development Activities
Sep 22, 2011
PDF 7.7 KB Add to Briefcase
Showing 1-20 of 331 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase